IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 203 filers reported holding IMMUNOGEN INC in Q4 2018. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,967 | +78.7% | 565 | +112.4% | 0.00% | – |
Q2 2023 | $5,019 | +531.3% | 266 | +28.5% | 0.00% | – |
Q1 2023 | $795 | -22.6% | 207 | 0.0% | 0.00% | – |
Q4 2022 | $1,027 | +2.7% | 207 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 207 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | 0.0% | 207 | -5.5% | 0.00% | – |
Q1 2022 | $1,000 | 0.0% | 219 | +138.0% | 0.00% | – |
Q4 2021 | $1,000 | -50.0% | 92 | -74.1% | 0.00% | – |
Q2 2020 | $2,000 | 0.0% | 355 | -25.7% | 0.00% | – |
Q1 2020 | $2,000 | -66.7% | 478 | -56.9% | 0.00% | – |
Q4 2019 | $6,000 | +500.0% | 1,109 | +238.1% | 0.00% | – |
Q3 2019 | $1,000 | 0.0% | 328 | +25.7% | 0.00% | – |
Q2 2019 | $1,000 | 0.0% | 261 | 0.0% | 0.00% | – |
Q1 2019 | $1,000 | 0.0% | 261 | 0.0% | 0.00% | – |
Q4 2018 | $1,000 | -50.0% | 261 | +16.0% | 0.00% | – |
Q3 2018 | $2,000 | 0.0% | 225 | 0.0% | 0.00% | – |
Q2 2018 | $2,000 | -50.0% | 225 | -35.5% | 0.00% | – |
Q1 2018 | $4,000 | +100.0% | 349 | -8.6% | 0.00% | – |
Q4 2017 | $2,000 | -83.3% | 382 | -74.7% | 0.00% | – |
Q3 2017 | $12,000 | 0.0% | 1,507 | -6.2% | 0.00% | – |
Q2 2017 | $12,000 | +140.0% | 1,607 | +10.8% | 0.00% | – |
Q1 2017 | $5,000 | -16.7% | 1,450 | -55.5% | 0.00% | – |
Q4 2016 | $6,000 | -50.0% | 3,256 | -31.4% | 0.00% | – |
Q3 2016 | $12,000 | -25.0% | 4,746 | -10.1% | 0.00% | – |
Q2 2016 | $16,000 | -77.5% | 5,277 | -35.7% | 0.00% | – |
Q1 2016 | $71,000 | -9.0% | 8,204 | +41.7% | 0.00% | – |
Q4 2015 | $78,000 | +36.8% | 5,790 | -2.7% | 0.00% | – |
Q3 2015 | $57,000 | -52.5% | 5,951 | -29.3% | 0.00% | – |
Q2 2015 | $120,000 | +87.5% | 8,415 | +17.9% | 0.00% | – |
Q1 2015 | $64,000 | +120.7% | 7,135 | +50.5% | 0.00% | – |
Q4 2014 | $29,000 | -35.6% | 4,740 | +10.2% | 0.00% | – |
Q3 2014 | $45,000 | -27.4% | 4,300 | -16.7% | 0.00% | – |
Q2 2014 | $62,000 | -18.4% | 5,165 | 0.0% | 0.00% | – |
Q1 2014 | $76,000 | +8.6% | 5,165 | +7.6% | 0.00% | – |
Q4 2013 | $70,000 | -21.3% | 4,800 | -9.4% | 0.00% | – |
Q3 2013 | $89,000 | +1.1% | 5,300 | -0.6% | 0.00% | – |
Q2 2013 | $88,000 | – | 5,333 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 10,906,962 | $69,914,000 | 3.04% |
Fernwood Investment Management, LLC | 224,500 | $1,439,000 | 0.77% |
Telemetry Investments, L.L.C. | 272,000 | $1,744,000 | 0.66% |
Schonfeld Strategic Advisors LLC | 865,356 | $5,547,000 | 0.45% |
Virtus ETF Advisers LLC | 53,977 | $346,000 | 0.43% |
Endurant Capital Management LP | 210,800 | $1,351,000 | 0.41% |
SPHERA FUNDS MANAGEMENT LTD. | 500,000 | $3,205,000 | 0.38% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $726,000 | 0.37% |
Orbimed Advisors | 2,834,126 | $18,167,000 | 0.23% |
PINNACLE ASSOCIATES LTD | 1,322,231 | $8,476,000 | 0.16% |